Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
State by State Marijuana Laws
After a year of immense change, the United States continues to battle the COVID-19 pandemic and the opioid crisis.
Watch Now
CE Webinar
Dental Trauma and Facial Injuries
On-Demand
Each year, thousands of employees sustain on-the-job facial or eye injuries from accidents that could have been prevented with the proper selection
Mitchell
News Release
MGC Acquires QualCare Alliance Networks Inc.
San Diego, CA—Mitchell | Genex |Coventry, a leader in cost containment technology, provider networks, clinical services, pharmacy
Workers' Comp
Podcast
The PAID Act is Coming to Medicare—Are You Ready?
Workers' Comp
White Paper
Workers’ comp networks are constantly evolving
Network Evolution Today, we see constructive partnerships between providers and payers that include a wide variety of provider types and
Workers' Comp
News Release
Mitchell | Genex | Coventry Completes Acquisition of QualCare Alliance Networks Inc.
Deal demonstrates company's commitment to network expansion San Di